Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN

Yerushalmy-Feler, A; Pujol-Muncunill, G; Martin-de-Carpi, J; Kolho, KL; Levine, A; Olbjorn, C; Granot, M; Bramuzzo, M; Rolandsdotter, H; Mouratidou, N; Hradsky, O; Scarallo, L; Matar, M; Rimon, RM; Rinawi, F; Shalem, T; Najajra, H; de Meij, T; Aloi, M; Rodriguez-Belvis, MV; Alvisi, P; Schneider, AM; van Rheenen, P; Navas-Lopez, VM; Kiparissi, F; Barrio, J; Turner, D; Cohen, S – 2022